L. Fodor et al. / Tetrahedron Letters 51 (2010) 3205–3207
3207
1253
(m
C–O), 867
(
c
CArH, condensed benzene ring), 778
(c
CArH, para-
ppm, ** reversed assignments are also possible. Anal. Calcd for C17H17NO4S
(331.39): C, 61.61; H, 5.17; N, 4.23; S, 9.68. Found: C, 61.46; H, 5.33; N, 4.01; S,
9.87.
disubstituted ring), 679 (CCl2) cmÀ1
.
1H NMR d (500 MHz, CDCl3): 7.40 (2H,
m, H-2’,6’), 7.23 (2H, m, H-3’,5’), 7.17 (1H, s, H-9), 6.67 (1H, s, H-6), 5.00 (1H, d,
J = 12.1 Hz, SCH2), 4.46 (1H, d, J = 12.1 Hz, SCH2), 3.98 (3H, s, 8-OCH3), 3.88 (3H,
s, 7-OCH3), 2.38 (3H, s, CH3) ppm; 13C NMR d (125 MHz, CDCl3): 160.5 (C@O),
150.0 (C-7), 146.7 (C-8), 139.7 (C-4’), 133.3 (C-1’), 129.6 (C-3’), 128.7 (C-2’),
122.7 (C-5a), 122.2 (C-9a), 115.0 (C-9), 110.8 (C-6), 90.6 (C-1), 74.0 (C-9b), 37.9
(CH2) ppm. Anal. Calcd for C19H17Cl2NO3S (410.31): C, 55.62; H, 4.18; N, 3.41; S,
7.82. Found: C, 55.78; H, 4.01; N, 3.63; S, 8.08. Compounds 4a–c: the analytical
data were identical to those reported.14 Yields, 4a: 97%, 4b: 95%, 4c: 88%.
12. (a) Alcaide, B.; Almendros, P.; Aragoncillo, C. Chem. Rev. 2007, 107, 4437; (b)
Alcaide, B.; Almendros, P.; Redondo, M. Chem. Commun. 2006, 2616; (c) Alcaide,
B.; Aly, M.; Rodríguez, C.; Rodríguez-Vicente, A. J. Org. Chem. 2000, 65, 3453.
13. Dejaegher, Y.; Mangelinkx, P.; De Kimpe, N. J. Org. Chem. 2002, 67, 2075.
14. General procedure for the retro-Staudinger reaction of 3a–c and 4a–c. Preparation
of 1a–c and 6a–c. Azeto-1,3-thiazine 3a–c or 4a–c (0.66 mmol) was dissolved
in dry MeOH (40 mL). To this stirred solution, NaOMe (71 mg, 1.32 mmol) was
added. The reaction mixture was stirred at reflux for 15 min. After evaporation,
the residue was dissolved in CH2Cl2 (20 mL). The organic phase was extracted
with H2O (10 mL), dried (Na2SO4) and evaporated. Compounds 1a–c are
known.18 The atom numbering of compounds 3 and 4 was also used for
products 6. Compound 6a: white crystalline powder, mp 197–198 °C (from
15. General procedure for the oxidation of 3a–c. Preparation of 4a–c. Compounds
3a–c (1.0 g) were suspended in AcOH (10 mL), followed by the addition of
freshly prepared peroxyacetic acid18 (15 mL). After complete dissolution, the
reaction mixture was allowed to stand at room temperature for 1 d and then
poured onto ice (30 g). The crystals that separated were removed by filtration,
and washed with cold H2O (5 mL) and MeOH (5 mL). Compound 4a: white
crystalline powder, mp 160–161 °C (from EtOH), yield 98%. mmax (KBr disc)
1808 (
benzene ring), 750
monosubstituted ring), 679 (CCl2) cmÀ1
m
C@O), 1316 (
m
asSO2), 1268 (
CArH, monosubstituted ring), 691
1H NMR d (500 MHz, CDCl3): 7.52
m
C–O), 1138 (
m
sSO2), 841 (
c
CArH, condensed
(c
(
c
CArCAr,
.
(2H, m, H-2’,6’), 7.47 (2H, m, H-3’,5’)*, 7.47 (1H, m, H-4’)*, 7.41 (1H, s, H-6), 7.07
(1H, s, H-9), 5.30 (1H, d, J = 13.8 Hz, SCH2), 4.55 (1H, d, J = 13.8 Hz, SCH2), 4.04
(3H, s, 8-OCH3), 3.99 (3H, s, 7-OCH3) ppm, * two overlapping signals; 13C NMR d
(125 MHz, CDCl3): 159.6 (C@O), 151.8 (C-8), 151.0 (C-7), 134.1 (C-1’), 131.4 (C-
5a), 130.5 (C-4’), 129.3 (C-3’), 128.8 (C-2’), 126.8 (C-9a), 112.9 (C-9), 106.3 (C-
6), 91.5 (C-1), 74.6 (C-9b), 59.2 (CH2) ppm. Anal. Calcd for C18H15Cl2NO5S
(428.29): C, 50.48; H, 3.53; N, 3.27; S, 7.49. Found: C, 50.36; H, 3.77; N, 3.42; S,
7.62. Compound 4b: white crystalline powder, mp 118–120 °C (from EtOH),
yield 94%. mmax (KBr disc) 1803 (
sSO2), 838 ( CArH, condensed benzene ring), 818 (
ring), 669 (CCl2) cmÀ1 1H NMR d (500 MHz, CDCl3): 7.44 (2H, m, H-2’,6’)*, 7.44
m
C@O), 1320 (
m
asSO2), 1262 (
mC–O), 1140
EtOH), yield 94%.
m
max (KBr disc) 1300 (
CArH, condensed benzene ring), 778 (
CArCAr, monosubstituted ring) cmÀ1 1H NMR d (500 MHz, CDCl3): 7.64 (2H,
m
asSO2), 1264 (
m
C–O), 1126 (
m
sSO2), 851
(m
c
c
CArH, para-disubstituted
(c
c
CArH, monosubstituted ring), 688
.
(c
.
(2H, m, H-3’,5’)*, 7.40 (1H, s, H-6), 6.98 (1H, s, H-9), 5.27 (1H, d, J = 13.8 Hz,
SCH2), 4.49 (1H, d, J = 13.8 Hz, SCH2), 4.04 (3H, s, 8-OCH3), 3.98 (3H, s, 7-OCH3)
ppm, * two overlapping signals; 13C NMR d (125 MHz, CDCl3): 159.4 (C@O),
151.9 (C-8), 151.1 (C-7), 136.9 (C-4’), 132.6 (C-1’), 131.3 (C-5a), 130.2 (C-2’),
129.5 (C-3’), 126.2 (C-9a), 112.6 (C-9), 106.4 (C-6), 91.4 (C-1), 74.1 (C-9b), 59.0
(CH2) ppm. Anal. Calcd for C18H14Cl3NO5S (462.73): C, 46.72; H, 3.05; N, 3.03; S,
6.93. Found: C, 46.97; H, 3.28; N, 3.19; S, 7.16; Compound 4c: white crystalline
m, H-2’,6’), 7.55 (1H, s, H-6), 7.54 (1H, m, H-4’), 7.49 (2H, m, H-3’,5’), 6.86 (1H,
s, H-9), 5.10 (2H, s, SCH2), 4.05 (3H, s, 7-OCH3), 3.78 (3H, s, 8-OCH3) ppm; 13C
NMR d (125 MHz, CDCl3): 166.9 (C-9b), 152.5 (C-8),* 152.4 (C-7),* 138.3 (C-1’),
131.4 (C-5a), 131.1 (C-4’), 129.4 (C-2’), 128.9 (C-3’), 123.8 (C-9a), 113.5 (C-10),
105.2 (C-6), 66.6 (CH2) ppm, * reversed assignments are also possible. Anal.
Calcd for C16H15NO4S (317.36): C, 60.55; H, 4.76; N, 4.41; S, 10.10. Found: C,
60.39; H, 5.01; N, 4.23; S, 10.31. Compound 6b: white crystalline powder, mp
powder, mp 220–221 °C (from EtOH), yield 97%. mmax (KBr disc) 1802 (
1317 ( asSO2), 1264 ( C–O), 1137 ( sSO2), 841 ( CArH, condensed benzene
ring), 814
CArH, para-disubstituted ring), 670 (CCl2) cmÀ1 1H NMR
mC@O),
232–233 °C (from EtOH), yield 93%.
1124 sSO2), 877 CArH, condensed benzene ring), 849
disubstituted ring) cmÀ1 1H NMR d (500 MHz, CDCl3): 7.59 (2H, m, H-2’,6’),
m
max (KBr disc) 1304 (
m
asSO2), 1277 (
m
C–O),
m
m
m
c
(
m
(c
(c
CArH, para-
(c
.
d
.
(500 MHz, CDCl3): 7.39 (1H, s, H-6), 7.37 (2H, m, H-2’,6’), 7.25 (2H, m, H-
3’,5’), 7.03 (1H, s, H-9), 5.26 (1H, d, J = 13.8 Hz, SCH2), 4.50 (1H, d, J = 13.8 Hz,
SCH2), 4.04 (3H, s, 8-OCH3), 3.98 (3H, s, 7-OCH3), 2.39 (3H, s, CH3) ppm; 13C
NMR d (125 MHz, CDCl3): 159.6 (C@O), 151.7 (C-8), 150.9 (C-7), 140.8 (C-4’),
131.4 (C-5a), 130.9 (C-1’), 130.0 (C-3’), 128.8 (C-2’), 127.0 (C-9a), 112.9 (C-9),
106.3 (C-6), 91.6 (C-1), 74.5 (C-9b), 59.1 (CH2), 21.5 (CH3) ppm. Anal. Calcd for
C19H17Cl2NO5S (442.31): C, 51.59; H, 3.87; N, 3.17; S, 7.25. Found: C, 51.45; H,
4.10; N, 3.41; S, 7.08.
7.53 (1H, s, H-6), 7.46 (2H, m, H-3’,5’), 6.81 (1H, s, H-9), 5.07 (2H, s, SCH2), 4.03
(3H, s, 7-OCH3), 3.79 (3H, s, 8-OCH3) ppm; 13C NMR d (125 MHz, CDCl3): 165.8
(C-9b), 152.6 (C-7), 152.5 (C-8), 137.4 (C-4’), 136.6 (C-1’), 131.5 (C-5a), 130.8
(C-2’), 129.2 (C-3’), 123.4 (C-9a), 113.1 (C-9), 105.3 (C-6), 66.6 (CH2) ppm. Anal.
Calcd for C16H14ClNO4S (351.81): C, 54.62; H, 4.01; N, 3.98; S, 9.11. Found: C,
54.81; H, 3.78; N, 4.13; S, 9.37. Compound 6c: white crystalline powder, mp
214–215 °C (from EtOH), yield 92%.
1124 sSO2), 875 CArH, condensed benzene ring), 829
disubstituted ring) cmÀ1 1H NMR d (500 MHz, CDCl3): 7.52 (1H, s, H-6),*
m
max (KBr disc) 1302 (
m
asSO2), 1277 (
mC–O),
(
m
(c
(c
CArH, para-
16. Holly, S.; Sohár, P. In Theoretical and Technical Introduction to the Series
Absorption Spectra in the Infrared Region; Láng, L., Prichard, W. H., Eds.;
Akadémiai Kiadó: Budapest, 1975; p 113 (a) p 113; (b) pp 128–129.
17. Wuts, P. G. M.; Greene, T. W. Protective Groups in Organic Synthesis; Wiley
Interscience: Hoboken, New Jersey, 2007.
.
7.51 (2H, m, H-2’,6’),* 7.27 (2H, m, H-3’,5’), 6.89 (1H, s, H-9), 5.06 (2H, s, SCH2),
4.02 (3H, s, 7-OCH3), 3.77 (3H, s, 8-OCH3), 2.43 (3H, s, CH3) ppm, * reversed
assignments are also possible; 13C NMR d (125 MHz, CDCl3): 166.8 (C-9b),
152.36 (C-8),** 152.32 (C-7),** 141.4 (C-4’), 135.4 (C-1’), 131.4 (C-5a), 129.6 (C-
3’), 129.4 (C-2’), 123.9 (C-9a), 113.6 (C-9), 105.2 (C-6), 66.6 (CH2), 21.8 (CH3)
18. Szabó, J.; Fodor, L.; Szücs, E.; Bernáth, G.; Sohár, P. Pharmazie 1984, 39, 426.